Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies - Rogado, J.; Romero-Laorden, N.; Sanchez-Torres, J.M.; Ramos-Levi, A.M.; Pacheco-Barcia, V.; Ballesteros, A.I.; Arranz, R.; Lorenzo, A.; Gullon, P.; Garrido, A.; Serra López-Matencio, J.M.; Donnay, O.; et al. (Oncoimmunology, 2020)